Paliperidone palmitate for schizophrenia

Schizophrenia Bulletin

Volumn 38, Issue 6, 2012, Pages 1124-1127

  Nussbaum, Abraham M ^a,b   Stroup, T Scott ^c  

^a Behavioral Health   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Columbia University ^*  (United States)

Author keywords

meta analysis; paliperidone palmitate; schizophrenia; systematic review

Indexed keywords

PALIPERIDONE; PLACEBO; PROLACTIN; RISPERIDONE;

ARTICLE; COST; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; ISOXAZOLES; MALE; PALMITATES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 84869023734     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs099     Document Type: Article

References (1)

1. Nussbaum AM, Stroup TS. Paliperidone palmitate for schizophrenia. Cochrane Database Syst Rev. 2012s. Art. No.: CD008296. doi:10.1002/14651858. CD008296.pub2.